Retracted: Solitaire™ Stent Thrombectomy System in the Treatment of Acute Lower-Limb Ischemia: Comparisons in Safety and Effectiveness with Conventional Catheter-Directed Thrombolysis Therapy
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
This article has been retracted by Hindawi following an investigation undertaken by
the publisher [1]. This investigation has uncovered evidence of one or more of the
following indicators of systematic manipulation of the publication process:
Discrepancies in scope
Discrepancies in the description of the research reported
Discrepancies between the availability of data and the research described
Inappropriate citations
Incoherent, meaningless and/or irrelevant content included in the article
Peer-review manipulation
The presence of these indicators undermines our confidence in the integrity of the
article's content and we cannot, therefore, vouch for its reliability. Please note
that this notice is intended solely to alert readers that the content of this article
is unreliable. We have not investigated whether authors were aware of or involved
in the systematic manipulation of the publication process.
Wiley and Hindawi regrets that the usual quality checks did not identify these issues
before publication and have since put additional measures in place to safeguard research
integrity.
We wish to credit our own Research Integrity and Research Publishing teams and anonymous
and named external researchers and research integrity experts for contributing to
this investigation.
The corresponding author, as the representative of all authors, has been given the
opportunity to register their agreement or disagreement to this retraction. We have
kept a record of any response received.
Objective The study aimed to investigate the safety and efficacy of the Solitaire™ AB Stent System (ev3 Inc., Plymouth, MN, USA) for the treatment of acute lower extremity ischemia (ALLI) compared with conventional catheter-directed thrombolytic therapy. Methods Retrospective analysis of patients with ALLI treated in the Department of Interventional Radiology at the First Hospital of Nanjing from January 2017 to April 2020 divided into a conventional (CDT) group (n = 106) and a percutaneous mechanical thrombectomy (PMT) group (n = 55) according to the procedure. PMT was performed using the Solitaire™ AB stent system. The combined clinical outcomes of mortality, major amputation, recurrent ischemia, and major morbidity were compared between the two groups. Results Of the 161 patients, 128 (79.5%) did not have a composite clinical outcome after 12 months of follow-up, namely, 78 CDT patients and 50 PMT patients, with significant differences in composite clinical outcome (26.4% vs. 9.1%, P = 0.010) and mortality (19.8% vs. 7.3%, P = 0.037) between them. Thrombolytic drug dose (19.34 ± 5.93 vs. 13.55 ± 6.54 mg, P < 0.001) and length of hospital stay (8.29 ± 3.91 vs. 5.49 ± 1.18 days, P = 0.003) were significantly lower in the PMT group. Conclusion PMT with the Solitaire™ AB Stent System is safer and more effective in treating patients with Rutherford stage I-IIB ALLI, with the advantage of rapid opening of obstructed vessels, shorter thrombolysis time, reduced thrombolytic dose, and improved blood flow to the infrapopliteal vessels.
This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium,
provided the original work is properly cited.
scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.